Aktis Oncology, Inc. Investing Cash Flow
Aktis Oncology, Inc. (AKTS) reported Investing Cash Flow of -$248.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- Aktis Oncology, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$268.71M, a 494.32% decline year-over-year.
- Aktis Oncology, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $20.54M, a 47.39% decline year-over-year.
- Aktis Oncology, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $68.14M.
- Aktis Oncology, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $39.04M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month |
|---|---|---|
| 2026-06-30 | -$268.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$248.17M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $20.54M 10-Q · filed 2026-05-11 | |
| 2025-06-30 | $68.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $107.19M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $39.04M 10-Q · filed 2026-05-11 |